The SBIR and STTR programs fund a diverse portfolio of startups and small businesses across technology areas and markets to stimulate technological innovation, meet Federal research and development (R&D) needs, and increase commercialization to transition R&D into impact.
Join us next week, Wednesday, May 18 at 1:00pm ET to learn how we (the medtech community) can help ensure the SBIR/STTR programs are reauthorized and continue to support small businesses in developing innovative technologies that improve the lives of patients. Please RSVP here.
During this Zoom session, you’ll:
- Receive a legislative update on the progress of the SBIR/STTR programs
- Learn which legislators are playing a role in the congressional conference committee that is reconciling two versions of legislation that need to include the SBIR/STTR programs
- Learn about the difference between – the House-passed, COMPETES Act, and the Senate’s US Innovation and Competitiveness Act (USICA)
- Learn how you can help advocate for SBIR/STTR
This is a great opportunity to understand the role the legislative process plays in making sure grant programs like the SBIR/STTR are accessible to the medtech community.